Article Versions Notes

Al-Ibraheem A, Abdlkadir AS, Hasasna N, Alalawi H, Mohamedkhair A, Al-Yazjeen S, Obeidat S, Rabei O, Al-Jarrah D, Shahin O, et al. The Role of [¹⁸F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma. Cancers. 2025; 17(2):231. https://doi.org/10.3390/cancers17020231

Al-Ibraheem, Akram, Ahmad Saad Abdlkadir, Nabil Hasasna, Hasan Alalawi, Ali Mohamedkhair, Salem Al-Yazjeen, Shahed Obeidat, Obayda Rabei, Dua’a Al-Jarrah, Omar Shahin, and et al. 2025. "The Role of [¹⁸F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma" Cancers 17, no. 2: 231. https://doi.org/10.3390/cancers17020231

Al-Ibraheem, A., Abdlkadir, A. S., Hasasna, N., Alalawi, H., Mohamedkhair, A., Al-Yazjeen, S., Obeidat, S., Rabei, O., Al-Jarrah, D., Shahin, O., Al-Rabi, K., Makoseh, M., & Almasri, N. (2025). The Role of [¹⁸F]FDG PET and Clinicopathologic Factors in Detecting and Predicting Bone Marrow Involvement in Non-Hodgkin Lymphoma. Cancers, 17(2), 231. https://doi.org/10.3390/cancers17020231